Home Services Clinical Affairs

Clinical Affairs


Clinical Affairs


Pre-IND Program Evaluation and Development, Clinical Development Planning,
Pre-IND meetings, IND services and filings, Phase I - IV Program Development
and Management, Protocol Design, Intelligent CRF Design, Scientific and Medical
Writing Services, Strategy and Design Meetings with Regulatory Agencies,
Pre-Launch Activities, Investigator Meetings, Focus Groups, Branding &
Positioning Activities, Drug Development Business Model Deployment, IRB
Management, Contract & Grant Negotiation and Management Services, Clinical
Trial Instructional Assistance, Opinion Leader Modeling and Positioning.

Synergy can independently manage and monitor your clinical trial, or work  as a
team with the sponsor's team as a true extension of existing research personnel.  
We have and are conducting clinical protocols in over 300 US centers, as well as
30 international research institutions.  Foreign protocols include France, Russia,
Germany, Israel, Canada.

Synergy places a great emphasis on the use of state-of-the-art technologies to
facilitate clinical trial management and monitoring.  Speak to us about real-time
monitoring strategies that can save time and money for your program.





Synergy Research Israel Based Clinical Trials




News & Events

  • AllTranz Developing Multi-Use Transdermal Patch   AllTranz, Lexington, Ky., is focused on t... Read more>>
  • Proximagen Signs Deal With Upsher-Smith Proximagen Neuroscience plc, a biotechnology company... Read more>>
  • Pending Litigation to Delay Launch of Generic Asacol Boehringer Ingelheim’s Roxane Laboratori... Read more>>
  • Food and Drug Administration NOTICES Meetings:   Internationa... Read more>>
  • New Class of Brain-Protecting Drugs Emerging Researchers have identified a compound that mim... Read more>>
  • FDA Requests More Information on Certriad LONDON (AP) - AstraZeneca PLC and Abbott Laborator... Read more>>
  • in vivo Pharmacodynamic Assay Trevigen offers a validated assay with higher sensitivity and... Read more>>
  • Statins May Slow Progression Of Multiple Sclerosis, New Study Finds A UCSF-led study exa... Read more>>
  • Novozymes Partnering With ProMetic Life Sciences Inc.Drug Discovery & Development - April 0... Read more>>
  • GSK Receives EMEA Approval for Duodart LONDON (AP) - Pharmaceutical company GlaxoSmithKline... Read more>>
  • T Cell Proliferation Assays ProImmune Ltd, a leader in epitope discovery, immunogenicity, an... Read more>>
  • FDA Says Additional Pixuvri Trial Needed, CTI Opens Drug to Expanded Access Cell Therapeutics... Read more>>